Checking patients' ejection fraction is important; if less than 40%, your patient has a reduced ejection fraction.
This means four medications can be used:
•Should they all be titrated to maximum doses?
•Is it important to reduce loop diuretics to the lowest dose?
•Should we be monitoring natriuretic peptide?
•What medications reduce symptoms versus increase life expectancy?
•All patients with CHF have a high CVD risk so what do we need to do to reduce these risk factors in terms of blood pressure, anti-platelet agents, anti-coagulation, blood glucose management and lipid-lowering?
•For reduced and preserved ejection fraction do they all need/get SGLT2 inhibitors?
Gerry Devlin will address these and other issues.
CHAPTERS:
00:00 Intro
00:47 Gerry Devlin (Presentation)
42:57 Audience Q&A
01:06:29 Outro
